title: Positive environmental modification of depressive phenotype and abnormal hypothalamic-pituitary-adrenal axis activity in female C57BL/6J mice during abstinence from chronic ethanol consumption.
abstract: Depression is a commonly reported co-morbidity during rehabilitation from alcohol use disorders and its presence is associated with an increased likelihood of relapse. Interventions which impede the development of depression could be of potential benefit if incorporated into treatment programs. We previously demonstrated an ameliorative effect of physical exercise on depressive behaviors in a mouse model of alcohol abstinence. Here, we show that environmental enrichment (cognitive and social stimulation) has a similar beneficial effect. The hypothalamic-pituitary-adrenal (HPA) axis is a key physiological system regulating stress responses and its dysregulation has been separably implicated in the pathophysiology of depression and addiction disorders. We performed a series of dexamethasone challenges and found that mice undergoing 2 weeks of alcohol abstinence had significantly greater corticosterone and ACTH levels following a DEX-CRH challenge compared to water controls. Environmental enrichment during alcohol abstinence corrected the abnormal DEX-CRH corticosterone response despite a further elevation of ACTH levels. Examination of gene expression revealed abstinence-associated alterations in glucocorticoid receptor (Gr), corticotrophin releasing hormone (Crh) and pro-opiomelanocortin (Pomc1) mRNA levels which were differentially modulated by environmental enrichment. Overall, our study demonstrates a benefit of environmental enrichment on alcohol abstinence-associated depressive behaviors and HPA axis dysregulation.
authors.affiliation: Behavioural Neurosciences Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne Melbourne, VIC, Australia.
authors.forename: Terence Y
authors.initials: TY
authors.lastname: Pang
authors.forename: Xin
authors.initials: X
authors.lastname: Du
authors.forename: William A
authors.initials: WA
authors.lastname: Catchlove
authors.forename: Thibault
authors.initials: T
authors.lastname: Renoir
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Lawrence
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Hannan
keywords: GR; HPA axis; abstinence; alcohol; depression; dexamethasone; environmental enrichment; pomc1
references.citation: Neuropsychopharmacology. 2006 Mar;31(3):525-34
references.pmid: 16123762
references.citation: Transl Psychiatry. 2012 Jul 03;2:e133
references.pmid: 22760557
references.citation: Alcohol. 2004 May;33(1):63-71
references.pmid: 15353174
references.citation: J Neurosci. 2012 May 30;32(22):7563-71
references.pmid: 22649234
references.citation: Neurosci Biobehav Rev. 2012 Jan;36(1):696-726
references.pmid: 22037449
references.citation: J Neural Transm (Vienna). 2010 Apr;117(4):513-9
references.pmid: 20191296
references.citation: Neuropharmacology. 2012 Sep;63(4):635-41
references.pmid: 22634364
references.citation: Alcohol Clin Exp Res. 2001 Jul;25(7):999-1005
references.pmid: 11505024
references.citation: Curr Pharm Des. 2013;19(40):7065-80
references.pmid: 23574443
references.citation: Biol Psychiatry. 2003 Jan 1;53(1):75-84
references.pmid: 12513947
references.citation: Pharmacol Biochem Behav. 2012 Mar;101(1):132-7
references.pmid: 22212452
references.citation: Brain Res. 2010 Feb 16;1314:206-18
references.pmid: 19699187
references.citation: Trends Neurosci. 2007 Aug;30(8):399-406
references.pmid: 17629579
references.citation: Behav Brain Res. 2012 Sep 1;234(1):1-10
references.pmid: 22705101
references.citation: Int J Neuropsychopharmacol. 2005 Dec;8(4):557-67
references.pmid: 16202182
references.citation: Psychopharmacology (Berl). 2009 Jun;204(3):391-402
references.pmid: 19224200
references.citation: Alcohol Clin Exp Res. 2009 Jan;33(1):129-38
references.pmid: 19076732
references.citation: Psychopharmacology (Berl). 2011 Nov;218(1):203-15
references.pmid: 21735074
references.citation: Ann N Y Acad Sci. 2008 Oct;1141:105-30
references.pmid: 18991954
references.citation: Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):17145-50
references.pmid: 18955698
references.citation: J Neurosci. 2003 Jun 1;23(11):4785-90
references.pmid: 12805318
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9070-5
references.pmid: 18591672
references.citation: J Biol Chem. 1986 Apr 5;261(10):4555-61
references.pmid: 3957908
references.citation: Alcohol Clin Exp Res. 2000 Dec;24(12):1836-49
references.pmid: 11141043
references.citation: Hum Mol Genet. 2009 Feb 15;18(4):753-66
references.pmid: 19008301
references.citation: Neuropsychopharmacology. 2011 Sep;36(10):2062-75
references.pmid: 21677651
references.citation: J Neurosci. 2002 Sep 15;22(18):7840-3
references.pmid: 12223535
references.citation: Neuropsychopharmacology. 2009 Apr;34(5):1209-22
references.pmid: 18563059
references.citation: J Neuroendocrinol. 2004 May;16(5):423-31
references.pmid: 15117335
references.citation: Brain Res. 2012 Mar 20;1444:27-37
references.pmid: 22341871
references.citation: Alcohol Clin Exp Res. 2011 Oct;35(10):1876-83
references.pmid: 21575018
references.citation: Neuropsychopharmacology. 2012 Jun;37(7):1579-87
references.pmid: 22334125
references.citation: Neuropsychopharmacology. 2013 Aug;38(9):1625-35
references.pmid: 23503126
references.citation: Neuropsychopharmacology. 2009 Dec;34(13):2767-78
references.pmid: 19741591
references.citation: Eur J Pharmacol. 2012 Mar 15;679(1-3):16-23
references.pmid: 22285855
references.citation: J Pharmacol Exp Ther. 2002 May;301(2):774-84
references.pmid: 11961084
references.citation: J Neurosci. 2004 Oct 27;24(43):9714-22
references.pmid: 15509760
references.citation: J Affect Disord. 2013 May 15;148(1):12-27
references.pmid: 23415826
references.citation: J Neurosci. 2008 May 21;28(21):5602-10
references.pmid: 18495894
references.citation: Physiol Behav. 2009 Jan 8;96(1):169-73
references.pmid: 18938187
references.citation: Ann Gen Hosp Psychiatry. 2004 Dec 14;3(1):15
references.pmid: 15598349
references.citation: Behav Sci (Basel). 2012 Jun 21;2(2):135-71
references.pmid: 23077729
references.citation: Brain Res Mol Brain Res. 1994 Jun;23(4):349-53
references.pmid: 8090075
references.citation: Endocrinology. 1990 Jun;126(6):2960-4
references.pmid: 2161741
references.citation: Eur J Neurosci. 2008 Oct;28(8):1641-53
references.pmid: 18979677
references.citation: World J Pediatr. 2012 Aug;8(3):197-206
references.pmid: 22886191
references.citation: Alcohol Clin Exp Res. 2002 Oct;26(10):1529-38
references.pmid: 12394286
references.citation: Eur J Neurosci. 2013 Jun;37(11):1803-10
references.pmid: 23551162
references.citation: Neuroscience. 2008 Oct 28;156(4):1017-27
references.pmid: 18801418
references.citation: J Neurosci. 2013 Feb 13;33(7):2961-72
references.pmid: 23407954
references.citation: Alcohol Clin Exp Res. 2001 May;25(5):687-91
references.pmid: 11371718
references.citation: Neuropharmacology. 2012 Jan;62(1):270-7
references.pmid: 21807004
references.citation: Ann N Y Acad Sci. 2009 Oct;1179:179-98
references.pmid: 19906240